What are some of the recent trends in China’s life sciences landscape? What should your company know about the regulatory framework, registration and clinical trials in China?
Horsten International, China consultant with a long track record in life sciences, will discuss the market entry modes and typical challenges for Belgian life sciences companies wanting to enter the Chinese market.
Cisema, a leading provider of regulatory affairs, quality assurance, clinical research, product testing & safety certification exclusively for the China and Hong Kong markets, will provide insights into regulatory strategies for market entry and beyond during the BCECC’s webinar “Life Science Regulations and Opportunities in China” on February 22, 2024 at 10:30 CET (17:30 CST).
Agenda:
10:30-10:35: Opening words by Mr. Bart Horsten, Board Member of the BCECC
10:35-10:50: Presentation by Mr. Bart Horsten, Managing Director of Horsten International
10:50-11:40: Presentation by Ms. Victoria Caldy, Business Development & Marketing Director of Cisema
11:40-11:55: Company testimonial by Mr. Nicolas Deleye, Director International Business Development of Flen Health
11:55-12:10: Q&A session
12:10-12:15: Closing remarks
Location:
Zoom (link will be sent out to the participants one day before the event)
Registration:
Free of charge, but registration is mandatory
Please click here to watch the webinar’s recording on our YouTube channel.